Answers are grounded in this paper and cite their sources.
Epigenetic clocks-statistical models that estimate biological age from DNA methylation patterns-are increasingly used or proposed for use in both biomedical and non-biomedical contexts. This article argues that the use of epigenetic clocks in these contexts introduces specific ethical problems. Three sets of problems are identified. The first concerns the measure itself: epigenetic age is a model-dependent estimate of a contested concept, and treating it as a policy target risks decoupling it from its intended outcomes. The second concerns its substitution for chronological age: biological testing introduces risks of temporal instability, differential accuracy across demographic groups, expanded inferential scope beyond what individuals have consented to have assessed, and unequal access to score-improving interventions. The third and deepest concern is structural inequity. Epigenetic clocks accurately capture the biological effects of social disadvantage, and policies that impose further burdens on structurally disadvantaged groups using epigenetic age risk entrenching that disadvantage under the guise of scientific objectivity. The analysis concludes that defensible use requires population-specific validation, transparency about inferential scope, and prior assessment of distributional effects on disadvantaged groups.
No takes yet. Share an insight, caveat, or question.
Nicolai Wohns (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: